Stay updated on DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Sign up to get notified when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.

Latest updates to the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check27 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision: v3.4.2 has been added. The lapse in government funding notice and the prior v3.4.1 revision note were removed, and the revision history was updated.SummaryDifference0.4%

- Check63 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center’s status, along with a version update from 3.4.0 to 3.4.1, were added.SummaryDifference0.4%

- Check70 days agoChange DetectedA glossary display was added to improve understanding of terms on the study page. In addition, there are minor text and version updates (new QC criteria label and Revision: v3.4.0) and removal of similar old labels.SummaryDifference0.2%

- Check84 days agoChange DetectedThe footer revision notice was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.